Sunday 11 October 2026 Export all DOC data to Excel Powerpack

Healthpeak Properties, Inc.

DOC Real Estate Reit Healthcare Facilities

Healthpeak Properties, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.8 billion, up 4.52% from fiscal 2024. In the quarter to June 2026, revenue grew 11.1%, EPS grew 60.0%, free cash flow fell 30.5% and total debt rose 11.0%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for five consecutive years, operating cash flow growth for five.

18.80 0.28 +1.51%
Market cap
$13.1B
P/E
53.8×
Fwd P/E
71.3×
Dividend yield
8.10%
F-score
4/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
160.80 57.91 35.77 27.35 38.81 38.27 344.70 12.52 29.78 22.22
Piotroski F-Score
4 6 5 5 8 6 5 5 4 6
P/S ratio
3.97 5.07 5.02 6.65 10.26 9.89 9.60 7.15 6.57 6.53
P/FCF ratio
32.98 12.29 31.23 0.00 17.67 161.80 0.00 6.73 9.90 14.29
P/Operating CF
38.06 48.31 47.38 66.23 86.86 74.42 78.79 61.22 58.07 64.56
P/B ratio
1.37 1.51 1.59 1.91 2.76 2.23 2.57 2.03 2.17 2.34
Price to Tangible BV
1.51 1.68 1.67 2.03 2.97 2.40 2.67 2.13 2.34 2.55
EV/Sales
7.26 8.23 8.10 9.74 13.40 13.66 12.91 10.09 10.79 10.79
EV/EBITDA
13.90 17.34 16.43 20.84 27.79 28.82 24.62 18.49 21.04 17.33
EV/Operating CF
16.38 20.76 18.47 22.30 31.95 29.62 27.24 21.96 23.55 18.92
EV/FCF
60.42 19.94 50.35 (219.14) 23.08 223.30 (19.96) 9.49 16.25 23.59
Quick Ratio
0.86 0.36 0.34 0.23 0.34 0.20 0.30 0.48 0.31 0.44
Current Ratio
2.82 2.56 0.67 0.72 0.90 0.46 0.72 0.64 1.09 2.37
Net Debt/EBITDA
6.32 6.66 6.24 6.61 6.52 7.94 6.05 6.18 8.23 6.83
Debt/Assets
48.48% 43.72% 43.80% 41.20% 40.44% 39.56% 42.77% 43.78% 55.94% 58.31%
Debt/Equity
1.21 0.96 1.00 0.90 0.87 0.86 0.90 0.85 1.41 1.55
Asset Turnover
0.14 0.15 0.14 0.13 0.12 0.11 0.09 0.09 0.12 0.11
Operating CF/Net income
17.76 4.42 3.14 1.81 1.58 1.84 19.23 0.80 2.05 1.94
Capex/Depreciation
(0.96) 0.05 (0.93) (1.60) 0.51 (1.05) (2.90) 1.93 0.67 (0.39)
Interest Coverage
1.70 1.13 2.11 1.99 2.00 0.70 1.32 1.15 1.25 1.53
ROE
0.82% 3.04% 4.33% 6.99% 7.00% 5.89% 0.67% 17.48% 7.16% 7.99%
ROA
0.35% 1.36% 1.93% 3.21% 3.22% 2.75% 0.33% 7.90% 2.77% 3.37%
ROIC
1.86% 1.12% 1.94% 1.59% 1.51% 0.71% 1.43% 1.57% 1.79% 2.96%
Return on Tangible Assets
0.41% 1.43% 2.37% 3.89% 3.99% 3.84% 0.54% 10.51% 3.84% 5.27%
Average Days of Receivables
10.13 10.38 9.34 9.46 9.37 9.38 13.20 14.76 8.04 7.73
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
3.20% 3.60% 4.36% 6.36% 5.18% 5.67% 7.50% 8.12% 4.80% 4.87%
Intangible Assets out of Total Assets
0.04 0.04 0.02 0.03 0.03 0.03 0.02 0.02 0.03 0.03
Share Based Compensation of Revenue
0.51% 0.58% 0.66% 1.28% 0.96% 1.06% 0.00% 0.00% 0.00% 0.00%
Graham Net Nets
(0.98) (0.66) (0.76) (0.59) (0.39) (0.51) (0.41) (0.45) (0.66) (0.63)
Graham Number
5.13 10.27 12.59 16.70 16.56 15.51 5.49 26.28 15.29 19.58
Earnings Yield
0.62% 1.73% 2.80% 3.66% 2.58% 2.61% 0.29% 7.98% 3.36% 4.50%
Free Cash Flow Yield
3.03% 8.14% 3.20% (0.67%) 5.66% 0.62% (6.74%) 14.86% 10.10% 7.00%
Revenue per Share
4.06 4.00 3.99 3.83 3.52 3.10 2.55 2.53 3.94 4.56
Operating CF per Share
1.80 1.58 1.75 1.67 1.48 1.43 1.74 1.80 1.81 2.60
Capex per Share
(1.31) 0.07 (1.11) (1.84) 0.57 (1.24) (4.11) 2.37 0.81 (0.52)
Free Cash Flow per Share
0.49 1.65 0.64 (0.17) 2.04 0.19 (2.37) 4.17 2.62 2.08
Cash per Share
0.77 0.27 0.31 0.24 0.39 0.21 0.19 0.30 0.18 0.29
Shareholders Equity per Share
11.70 13.40 12.57 13.33 13.10 13.74 13.71 13.84 11.94 12.72
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
11.70 13.40 12.57 13.33 13.10 13.74 13.71 13.84 11.94 12.72
Free Cash Flow
339.32 1,114.76 350.84 (91.62) 1,100.79 100.59 (1,154.66) 1,963.46 1,227.13 973.40
Working Capital
1,306.14 1,128.50 (213.90) (217.38) (79.14) (411.54) (128.33) (140.57) 34.52 572.70
Capital Expenditures
(912.63) 44.27 (605.40) (991.88) 305.54 (657.84) (2,000.73) 1,114.75 380.09 (240.73)
Net Current Asset Value
(10,168.50) (9,029.39) (8,379.51) (8,033.53) (7,522.52) (8,281.06) (7,036.21) (5,954.95) (8,057.26) (8,827.90)
EV/EBIT
39.47 70.44 41.86 58.24 80.58 145.95 93.36 43.41 51.90 32.38
Capex to Sales
0.32 (0.02) 0.28 0.48 (0.16) 0.40 1.61 (0.94) (0.21) 0.11
Price to Operating Income
21.54 43.40 25.96 39.76 61.68 105.75 69.42 30.76 31.61 19.61
Other line items
Depreciation/Fixed assets
0.06 0.06 0.05 0.05 0.05 0.06 0.08 0.06 0.05 0.05
Cash ROIC
1.83% 6.21% 2.52% (0.66%) 8.19% 0.73% (9.05%) 16.07% 9.05% 6.38%
Accounts Receivable Turnover
36.39 40.72 39.92 40.37 41.69 37.77 26.67 26.80 43.06 45.28
Accounts Payable Turnover
1.56 1.55 1.26 1.13 1.02 1.28 0.95 0.95 1.63 1.74
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
232.27 246.31 265.92 326.72 356.55 354.77 412.10 377.46 220.09 206.31
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
77.57 66.32 54.63 51.06 45.48 43.56 46.51 44.45 42.92 47.02
Average Payables
721.93 691.27 714.84 763.93 758.00 609.07 424.56 396.66 409.55 424.07
Average Assets
20,137.14 17,818.56 15,735.04 15,514.38 15,588.81 14,976.49 13,375.72 13,403.51 14,923.86 18,604.56
Average Common Equity
8,598.94 7,965.53 7,029.32 7,120.68 7,174.36 6,978.71 6,590.03 6,053.76 5,768.12 7,843.81

Fold the line items

Columns are period end dates